Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

60%

3 of 5 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

N/A

3(50.0%)

Phase 3

2(33.3%)

Phase 1

1(16.7%)

6Total

N/A(3)

Phase 3(2)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT07279415Not ApplicableNot Yet Recruiting

Activate Tennessee: A CHW-Supported Program for Patient Activation

Role: collaborator

NCT03269994Phase 3Completed

Does Cefoxitin or Piperacillin-Tazobactam Prevent Postoperative Surgical Site Infections After Pancreatoduodenectomy?

Role: collaborator

NCT03850912Not ApplicableCompleted

Symptom Management Implementation of Patient Reported Outcomes in Oncology

Role: collaborator

NCT02123797Completed

Building a Multidisciplinary Bridge Across the Quality Chasm in Thoracic Oncology

Role: lead

NCT03594708Not ApplicableUnknown

Immunonutrition in Ulcerative Colitis

Role: lead

NCT00487045Phase 1Completed

Prevention and/or Reduction of Hemorrhoids and/or Thrombosed External Hemorrhoids Using the HEM-AVERT Perianal Stabilizer Instrument

Role: collaborator

NCT00179491Phase 3Completed

Study of the Therapeutic Effects of Intercessory Prayer (STEP)

Role: collaborator

All 7 trials loaded